Your browser doesn't support javascript.
loading
Successful Lung Transplant After Prolonged Extracorporeal Membrane Oxygenation (ECMO) in a Child With Pulmonary Hypertension: A Case Report.
Tissot, Cecile; Habre, Walid; Soccal, Paola; Hug, Maja Isabel; Bettex, Dominique; Pellegrini, Michel; Aggoun, Yacine; Mornand, Anne; Kalangos, Afksendyios; Rimensberger, Peter; Beghetti, Maurice.
Afiliação
  • Tissot C; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Habre W; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Soccal P; Division of Pneumology, University Hospital of Geneva, Geneva, Switzerland.
  • Hug MI; Institute of Anesthesiology, University Hospital of Zurich, Zurich, Switzerland.
  • Bettex D; Institute of Anesthesiology, University Hospital of Zurich, Zurich, Switzerland.
  • Pellegrini M; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Aggoun Y; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Mornand A; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Kalangos A; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Rimensberger P; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
  • Beghetti M; Department of the Child and Adolescent, Children's University Hospital of Geneva, Geneva, Switzerland.
Res Cardiovasc Med ; 5(3): e32545, 2016 Aug.
Article em En | MEDLINE | ID: mdl-27800456
ABSTRACT

INTRODUCTION:

The use of extracorporeal membrane oxygenation (ECMO) is considered a risk factor for, or even a potential contraindication to, lung transplantation. However, only a few pediatric cases have been described thus far. CASE PRESENTATION A 9-year-old boy with idiopathic pulmonary arterial hypertension developed cardiac arrest after the insertion of a central catheter. ECMO was used as a bridge to lung transplantation. However, after prolonged resuscitation, he developed medullary ischemia and medullary syndrome. After 6 weeks of ECMO and triple combination therapy for pulmonary hypertension, including continuous intravenous prostacyclin, he was weaned off support, and after 2 weeks, bilateral lung transplantation was performed. At 4 years post-transplant, he has minimal problems. The medullary syndrome has also alleviated. He is now back to school and can walk with aids.

CONCLUSIONS:

Increasing evidence supports the use of ECMO as a bridge to LT, reporting good outcomes. In the modern era of PAH therapy, it is feasible to use prolonged ECMO support as a bridge to lung transplant, with the aim of weaning off this support; however, its use requires more experience and knowledge of long-term outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Res Cardiovasc Med Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Res Cardiovasc Med Ano de publicação: 2016 Tipo de documento: Article